Market Today: Mixed Reactions Amid Corporate Developments

? UnitedHealth UNH shares fell after the resignation of CEO Andrew Witty and the suspension of its 2025 outlook due to rising medical costs. Stephen Hemsley has been appointed as the new CEO.

? Affimed (AFMD) announced plans to file for insolvency proceedings in Germany, citing insufficient funds to continue operations, leading to a sharp decline in its stock price.

? Boeing BA received clearance from China to resume aircraft deliveries following a trade agreement with the U.S., easing previous tensions and potentially boosting Boeing's sales.

? Tesla TSLA is under investigation by the U.S. National Highway Traffic Safety Administration regarding its Full Self-Driving software, particularly its use in low-visibility conditions, affecting its robotaxi service plans.

? 3M MMM agreed to a $285 million settlement with New Jersey over PFAS-related claims, impacting its financial results for the second quarter.

? Robinhood HOOD announced its acquisition of WonderFi Technologies to enhance its crypto offerings in Canada, with the deal expected to close in the second half of the year.

? Landsea Homes LLSEA surged after New Home agreed to acquire it for $11.30 per share, representing a significant premium over its previous closing price.

? GSK GSK and iTeos Therapeutics IITOS decided to discontinue a lung cancer treatment development after failing to meet key trial endpoints.

? Samsung (SSNLF) launched the ultra-thin Galaxy S25 Edge, while Apple AAPL is reportedly preparing to release the iPhone 17 Air, intensifying competition in the smartphone market.

? ZoomInfo (ZI) raised its 2025 revenue guidance and announced a strategic shift with the launch of its Go-To-Market Studio, reflecting its focus on upmarket growth.

? Microvast MVST reported record first-quarter profits and set a 2025 revenue target, driven by strong sales in the EMEA region.

? MicroVision MVIS outlined revenue targets and expansion plans into defense and industrial sectors, despite a slow automotive market.

? Archer Aviation ACHR detailed plans for piloted Midnight flights and a launch in the UAE, alongside advancements in its defense platform.

? Rigetti Computing RGTI aims to achieve over 100 qubits by the end of 2025, supported by new deals with DARPA and Quanta.

? DaVita DVA maintained its 2025 guidance despite a recent cybersecurity incident, with phosphate binders expected to contribute positively to earnings.

? TPI Composites TTPIC revised its EBITDA margin guidance amid strategic reviews and tariff uncertainties, focusing on operational excellence.

? Coherus BioSciences CHRS projected significant revenue growth from its LOQTORZI product, supported by strategic partnerships and pipeline advancements.

? Arrowhead Pharmaceuticals ARWR is preparing for the commercial launch of plozasiran, with strong financial backing and a robust clinical pipeline.

? OncoCyte OOCX is advancing its clinical trials and rebranding initiative, targeting FDA submission and expanding its transplant center network.

? Northwest Bancshares NWBI announced a transition in its board chair position as part of its ongoing leadership evolution.